Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 18.9
(-0.37%)
CNY 18.9
(-0.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 943.7 Million CNY | -2.13% |
| 2022 | 964.27 Million CNY | 6.3% |
| 2021 | 907.16 Million CNY | 43.17% |
| 2020 | 633.63 Million CNY | 22.51% |
| 2019 | 517.22 Million CNY | 21.51% |
| 2018 | 425.65 Million CNY | 65.22% |
| 2017 | 257.61 Million CNY | 36.69% |
| 2016 | 188.47 Million CNY | 0.0% |
| 2014 | 175.81 Million CNY | 4.46% |
| 2013 | 168.3 Million CNY | 24.61% |
| 2012 | 135.06 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 230.22 Million CNY | -11.35% |
| 2024 Q2 | 305.78 Million CNY | 32.82% |
| 2024 Q3 | 231.43 Million CNY | -24.31% |
| 2023 Q2 | 249.44 Million CNY | -15.9% |
| 2023 Q3 | 163.03 Million CNY | -34.64% |
| 2023 Q4 | 259.68 Million CNY | 59.28% |
| 2023 FY | 943.7 Million CNY | -2.13% |
| 2023 Q1 | 296.61 Million CNY | 27.56% |
| 2022 Q3 | 249.05 Million CNY | 5.28% |
| 2022 FY | 964.27 Million CNY | 6.3% |
| 2022 Q4 | 232.52 Million CNY | -6.64% |
| 2022 Q2 | 236.56 Million CNY | -3.88% |
| 2022 Q1 | 246.12 Million CNY | 4.01% |
| 2021 Q2 | 218.75 Million CNY | 1.36% |
| 2021 Q1 | 215.83 Million CNY | 25.27% |
| 2021 Q4 | 236.63 Million CNY | 0.29% |
| 2021 FY | 907.16 Million CNY | 43.17% |
| 2021 Q3 | 235.94 Million CNY | 7.86% |
| 2020 Q3 | 176.48 Million CNY | 15.8% |
| 2020 Q1 | 132.44 Million CNY | -5.57% |
| 2020 FY | 633.63 Million CNY | 22.51% |
| 2020 Q2 | 152.41 Million CNY | 15.08% |
| 2020 Q4 | 172.29 Million CNY | -2.38% |
| 2019 Q2 | 119.44 Million CNY | 0.0% |
| 2019 FY | 517.22 Million CNY | 21.51% |
| 2019 Q4 | 140.24 Million CNY | 1.57% |
| 2019 Q3 | 138.08 Million CNY | 15.61% |
| 2019 Q1 | 119.44 Million CNY | 0.0% |
| 2018 FY | 425.65 Million CNY | 65.22% |
| 2017 FY | 257.61 Million CNY | 36.69% |
| 2016 FY | 188.47 Million CNY | 0.0% |
| 2014 FY | 175.81 Million CNY | 4.46% |
| 2013 FY | 168.3 Million CNY | 24.61% |
| 2012 FY | 135.06 Million CNY | 0.0% |